A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

04/10/25 — USF is ranked No. 13 in the world, No. 9 in the U.S., and No. 1 in Florida for the five-year period from 2020 to 2024, according to AIS Research Rankings released by the Association for ...

Biogen's $7.22 per share buyout offer signals confidence in Sage's commercial potential and drug pipeline. Read why SAGE ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neuroscience and neurodegenerative diseases with a market capitalization of $17.45 billion, finds itself at a ...

MANILA, Philippines — The government’s legal education regulator has ordered the closure of the College of Law of the University of Manila (UM) because of its “dismal performance” in bar ...